CHLA researcher to lead a new study on liquid biopsy for diagnosing ocular cancer in children
Recently, a researcher at Children's Hospital Los Angeles developed a new way to diagnose retinoblastoma by sampling the fluid at the...
Aug 10, 2023
Local kids with cancer getting free port shirts to ease anxiety
Canadian kids dealing with cancer, including those in Newmarket and area, will receive free port shirts they can customize thanks to a ...
Aug 8, 2023
Screening genes for the right treatment: New hope for children with cancer
In a landmark study of 125 Australian children with high-risk cancer—whose tumor cells were grown in the lab and tested against a suite...
Aug 8, 2023
Hope of cancer breakthrough as ‘groundbreaking pill’ annihilates ALL solid tumours in early study
In early studies, the targeted chemotherapy drug has shown to annihilate tumours without affecting surrounding healthy cells. Read more:...
Aug 3, 2023
As pediatric cancer rates rise and deaths fall, experts call attention to survivors
Although data shows mortality rates for childhood cancers continue to fall, a new report from the Centers for Disease Control and...
Jul 28, 2023
Survival of children with acute lymphatic leukemia has increased to 94%, study finds
The five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is evident from a...
Jul 17, 2023
Navigating cancer as a young adult: Going away to college
Dealing with cancer as a teenager or young adult living at home can be difficult, but what happens when you go away to college? Whether...
Jul 12, 2023
Healthy diet shown to lower cardiovascular disease risk in adult childhood cancer survivors
In a recent study published in BMC Medicine, researchers analyze cardiovascular illness risk across adult childhood cancer survivors...
Jul 11, 2023
BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia
BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute...
Jul 7, 2023
Lenalidomide Demonstrates Promising Activity in Pediatric Gliomas/Astrocytomas
The immunomodulatory agent lenalidomide (Revlimid) appeared clinically active and tolerable in pilocytic astrocytomas and optic pathway...
Jul 6, 2023

